COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW

Envoy Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$0.65−0.01 (-2.10%)

Close on Oct 19, 2026

Market cap: $68.04M
P/E (TTM): –
Dividend yield: –

Envoy Medical, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31
Stock-Based Compensation	0.21	0.24	0.18	0.17	0.15	0.16	0.15	0.14	0.14	0.12	–	–	–	–	–	–	–	–	–	–	–	–
Change in Accounts Receivable	-0.02	0.00	0.00	0.01	0.00	0.00	0.16	-0.02	0.02	-0.12	0.04	-0.05	0.01	-0.02	0.06	–	–	–	–	–	–	–
Change in Inventory	-0.10	0.04	0.13	-0.11	0.04	0.07	-0.14	0.20	-0.30	-0.14	0.09	-0.11	–	–	0.03	–	–	–	–	–	–	–
Change in Accounts Payable	0.31	-1.22	0.41	1.01	-0.04	0.01	-0.22	0.17	0.68	-0.64	-1.83	1.02	0.34	1.02	0.58	-0.51	0.23	0.04	-0.18	0.75	0.07	-0.01
Operating Cash Flow	-5.46	-6.06	-5.69	-4.33	-4.46	-3.73	-5.09	-2.62	-4.65	-5.59	-11	1.10	-4.03	-3.01	-2.38	-5.25	-0.40	-0.77	-0.89	-0.70	-0.41	-1.25
Capital Expenditures	–	–	-0.17	0	0.00	-0.01	0.53	-1.16	-0.25	-0.11	-0.02	-0.06	-0.01	-0.06	-0.04	–	–	–	–	–	–	–
Investing Cash Flow	–	–	-0.17	0	0.00	-0.01	0.53	-0.62	-0.79	-0.11	-0.02	-0.06	-0.01	-0.06	-0.04	–	–	–	0	0	-5.00	-420
Dividends Paid	–	–	0.00	0	-0.61	-1.21	-0.61	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Stock Issued	0	30	0	0.21	–	–	–	0	0	1.68	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	-0.11	28	6.04	2.60	4.44	3.55	5.62	5.92	2.24	6.43	-1.45	16	3.00	4.00	2.00	4.59	0.75	0.75	0.00	-0.01	4.99	423
Foreign Exchange Rate Adjustments	0.00	0.00	0	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	–	–	0.00	-0.01	–	–	–	–	–	–	–
Net Change in Cash	-5.57	22	0.18	-1.73	-0.03	-0.17	1.06	2.68	-3.20	0.73	-13	17	-1.05	0.93	-0.43	-0.84	0.35	-0.02	-0.88	-0.71	-0.42	2.13
Free Cash Flow	–	–	-5.86	-4.33	-4.46	-3.73	-4.56	-3.78	-4.89	-5.70	-11	1.04	-4.05	-3.07	-2.42	–	–	–	–	–	–	–
Income Taxes Paid	–	–	–	–	–	–	–	–	–	–	–	–	0.32	1.38	–	–	–	–	–	–	–	–
Interest Paid	0.01	0.01	0.01	0.00	0.01	0.01	0.02	0.00	0.01	0.01	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: -385.5%
Operating margin: -11411.1%
Net margin: -11304.8%
Return on equity, FY2025: 153.3%

Financial strength

Current ratio: 1.73
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 155.8%

Valuation

P/E ratio: –
Price to sales: 328.70
Price to book: 20.60
Dividend yield: –